BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33390186)

  • 1. CDK13 upregulation-induced formation of the positive feedback loop among circCDK13, miR-212-5p/miR-449a and E2F5 contributes to prostate carcinogenesis.
    Qi JC; Yang Z; Lin T; Ma L; Wang YX; Zhang Y; Gao CC; Liu KL; Li W; Zhao AN; Shi B; Zhang H; Wang DD; Wang XL; Wen JK; Qu CB
    J Exp Clin Cancer Res; 2021 Jan; 40(1):2. PubMed ID: 33390186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of long non-coding RNA UCA1 represses tumorigenesis and metastasis of osteosarcoma via miR-513b-5p/E2F5 axis.
    Zhang Z; Wu X; Han Q; Huang Z
    Anticancer Drugs; 2021 Jun; 32(6):602-613. PubMed ID: 33595944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The putative tumour suppressor miR-1-3p modulates prostate cancer cell aggressiveness by repressing E2F5 and PFTK1.
    Li SM; Wu HL; Yu X; Tang K; Wang SG; Ye ZQ; Hu J
    J Exp Clin Cancer Res; 2018 Sep; 37(1):219. PubMed ID: 30185212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNA-154-5p Inhibits Proliferation, Migration and Invasion by Targeting E2F5 in Prostate Cancer Cell Lines.
    Zheng Y; Zhu C; Ma L; Shao P; Qin C; Li P; Cao Q; Ju X; Cheng G; Zhu Q; Gu X; Hua L
    Urol Int; 2017; 98(1):102-110. PubMed ID: 27074041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of tumor suppressive role of microRNA-132 and its target gene in tumorigenesis of prostate cancer.
    Li SL; Sui Y; Sun J; Jiang TQ; Dong G
    Int J Mol Med; 2018 Apr; 41(4):2429-2433. PubMed ID: 29393367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E2F5 promotes prostate cancer cell migration and invasion through regulation of TFPI2, MMP-2 and MMP-9.
    Karmakar D; Maity J; Mondal P; Shyam Chowdhury P; Sikdar N; Karmakar P; Das C; Sengupta S
    Carcinogenesis; 2020 Dec; 41(12):1767-1780. PubMed ID: 32386317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SNHG16 contributes to breast cancer cell migration by competitively binding miR-98 with E2F5.
    Cai C; Huo Q; Wang X; Chen B; Yang Q
    Biochem Biophys Res Commun; 2017 Apr; 485(2):272-278. PubMed ID: 28232182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-β signaling.
    Dai Y; Wu Z; Lang C; Zhang X; He S; Yang Q; Guo W; Lai Y; Du H; Peng X; Ren D
    Theranostics; 2019; 9(21):6063-6079. PubMed ID: 31534537
    [No Abstract]   [Full Text] [Related]  

  • 9. CDK13 promotes lipid deposition and prostate cancer progression by stimulating NSUN5-mediated m5C modification of ACC1 mRNA.
    Zhang Y; Chen XN; Zhang H; Wen JK; Gao HT; Shi B; Wang DD; Han ZW; Gu JF; Zhao CM; Xue WY; Zhang YP; Qu CB; Yang Z
    Cell Death Differ; 2023 Dec; 30(12):2462-2476. PubMed ID: 37845385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of miR-449a-caused PrLZ overexpression promotes prostate cancer metastasis.
    Chen W; Liu Y; Chen H; Ning H; Ding K
    Int J Oncol; 2017 Aug; 51(2):435-444. PubMed ID: 28627667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. hMSCs-derived exosome circCDK13 inhibits liver fibrosis by regulating the expression of MFGE8 through miR-17-5p/KAT2B.
    Ma J; Li Y; Chen M; Wang W; Zhao Q; He B; Zhang M; Jiang Y
    Cell Biol Toxicol; 2023 Apr; 39(2):1-22. PubMed ID: 35484432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis.
    Barros-Silva D; Costa-Pinheiro P; Duarte H; Sousa EJ; Evangelista AF; Graça I; Carneiro I; Martins AT; Oliveira J; Carvalho AL; Marques MM; Henrique R; Jerónimo C
    Cell Death Dis; 2018 Feb; 9(2):167. PubMed ID: 29415999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deregulated E2F5/p38/SMAD3 Circuitry Reinforces the Pro-Tumorigenic Switch of TGFβ Signaling in Prostate Cancer.
    Majumder S; Bhowal A; Basu S; Mukherjee P; Chatterji U; Sengupta S
    J Cell Physiol; 2016 Nov; 231(11):2482-92. PubMed ID: 26919443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA‑34a inhibits esophageal squamous cell carcinoma progression by targeting E2F5.
    Jiang H; Guo Y; Huang K; Lu R; Peng X; Lin S
    J BUON; 2019; 24(6):2514-2522. PubMed ID: 31983127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-17-5p targets the p300/CBP-associated factor and modulates androgen receptor transcriptional activity in cultured prostate cancer cells.
    Gong AY; Eischeid AN; Xiao J; Zhao J; Chen D; Wang ZY; Young CY; Chen XM
    BMC Cancer; 2012 Oct; 12():492. PubMed ID: 23095762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTCF-induced upregulation of HOXA11-AS facilitates cell proliferation and migration by targeting miR-518b/ACTN4 axis in prostate cancer.
    Xing Z; Li S; Liu Z; Zhang C; Bai Z
    Prostate; 2020 Apr; 80(5):388-398. PubMed ID: 31971633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer.
    Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M
    J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-34a targets FMNL2 and E2F5 and suppresses the progression of colorectal cancer.
    Lu G; Sun Y; An S; Xin S; Ren X; Zhang D; Wu P; Liao W; Ding Y; Liang L
    Exp Mol Pathol; 2015 Aug; 99(1):173-9. PubMed ID: 26103003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo.
    Kiener M; Chen L; Krebs M; Grosjean J; Klima I; Kalogirou C; Riedmiller H; Kneitz B; Thalmann GN; Snaar-Jagalska E; Spahn M; Kruithof-de Julio M; Zoni E
    BMC Cancer; 2019 Jun; 19(1):627. PubMed ID: 31238903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-613 suppresses retinoblastoma cell proliferation, invasion, and tumor formation by targeting E2F5.
    Zhang Y; Zhu X; Zhu X; Wu Y; Liu Y; Yao B; Huang Z
    Tumour Biol; 2017 Mar; 39(3):1010428317691674. PubMed ID: 28351331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.